From the abstract: “This study aimed to map the geographic inequities in HPV vaccine non-uptake and identify its determinants among adolescent girls in Ethiopia.”
From the abstract: “This study examines immunization coverage, sociodemographic disparities, predictors of completion, and policy implementation effectiveness in Ghana using nationally representative data.”
From the abstract: “This study assessed hepatitis B vaccination coverage and its predictors among informal sector workers in Kejetia market, Kumasi, Ghana.”
From the abstract: “This study establishes a scalable and cost-effective bioreactor platform for the production of the CHIKV vaccine, highlighting the critical interplay between nutrient optimization and viral yield enhancement, while emphasizing the advantages of automated process control in bioreactors to facilitate large-scale, high-yield viral production.”
From the abstract: “Hence, this study was aimed at assessing prevalence, spatial patterns and determinants of zero-dose vaccination among children aged 12–23 months in SSA, 2025.”
From the abstract: “This study examined community members and healthcare workers' (HCWs) perceptions of the COVID-19 pandemic and vaccines in Nigeria, exploring factors that influence vaccine acceptance and hesitancy.”
From the abstract: “A retrospective cross-sectional analysis was conducted using routine diagnostic records from the Mpumalanga Provincial Veterinary Laboratory between January 2021 and December 2024.”
From the abstract: “This study evaluated the impact of HIV status, age, and gender of high-risk populations on HBV vaccination adherence and completion rate in Lagos state, Nigeria.”
From the abstract: “In those with isolated core antibodies, we explored the incidence of an anamnestic response based on post-first-dose anti-HBs > 10 IU/ml and>= 1-log increase from baseline. 616 adults (median age, 32.2 years, IQR [26.7–43.8]; 61.2% women) enrolled, including 333 contacts, 213 HCWs, and 70 PLWH.”
From the abstract: “We retrospectively estimated the financial and economic cost of COVID-19 vaccine delivery from a payer perspective, using a bottom-up approach.”